Beijing Tong Ren Tang Chinese Medicine Company Limited (FRA:TQR)

Market Cap	832.89M
Revenue (ttm)	200.41M
Net Income (ttm)	62.21M
Shares Out	n/a
EPS (ttm)	0.07
PE Ratio	13.39
Forward PE	13.56
Dividend	0.04 (3.94%)
Ex-Dividend Date	Jun 5, 2025

Volume	n/a
Average Volume	1,100
Open	0.9900
Previous Close	0.9850
Day's Range	0.9900 - 0.9900
52-Week Range	0.8100 - 1.1400
Beta	n/a
RSI	50.31
Earnings Date	Aug 8, 2025

About FRA:TQR

Beijing Tong Ren Tang Chinese Medicine Company Limited, together with its subsidiaries, engages in the manufacture, retail, and wholesale of healthcare products and Chinese medicine to wholesalers and individuals. It operates through three segments: Hong Kong, Mainland China, and Overseas. The company offers Chinese medical consultation and treatment services. It also operates retail outlets in Hong Kong and in other countries and regions in Asia, Oceania, North America, and Europe. It markets its products under the Tong Ren Tang brand name. Be...

• Industry: Drug Stores and Proprietary Stores
• Founded: 1669
• Employees: 782
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: TQR

Financial Performance

In 2024, FRA:TQR's revenue was 1.61 billion, an increase of 5.69% compared to the previous year's 1.52 billion. Earnings were 500.28 million, a decrease of -7.42%.

Financial numbers in HKD